The Arbitration Appeal Court of Moscow confirms the fine imposed on a pharmaceutical company for abuse of dominance (Novo Nordisk)

Appeal Court confirmed: “Novo Nordisk” violated the antimonopoly law* On 22 June 2015, the 9th Arbitration Appeal Court upheld the judgment of the Court of First Instance and pronounced legitimacy of the decision of the Federal Arbitration Service (FAS Russia) that “Novo Nordisk” Ltd. had violated of the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Russian Competition Authority, The Arbitration Appeal Court of Moscow confirms the fine imposed on a pharmaceutical company for abuse of dominance (Novo Nordisk), 22 June 2015, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 75767

Visites 60

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues